AMRX in the 13F filings
Amneal Pharmaceuticals Inc · CUSIP 03168L105
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 31
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 5 listed it in both
- Shares listed
- 16,508,922
- combined, among listed positions
- Reported value
- $205m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 19 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -12,019,776.
Managers listing AMRX in Q1 2026
31 of 31 holders
Largest increases and reductions, by shares
Increases
- Invesco Ltdexisting position · 3,188,659 shares now+1,437,941
- Fidelity (FMR LLC)existing position · 792,010 shares now+414,986
- Renaissance Technologies LLCexisting position · 276,637 shares now+260,237
- Quantbot Technologies LPexisting position · 176,779 shares now+143,649
- Winton Group Ltdnew position · 119,381 shares now+119,381
Reductions
- Citadel Advisors LLCexisting position · 577,419 shares now-5,598,318
- Millennium Management LLCexisting position · 369,733 shares now-2,990,465
- Susquehanna International Group LLPexisting position · 52,543 shares now-1,273,997
- D. E. Shaw & Co.existing position · 1,719,954 shares now-941,900
- ExodusPoint Capital Management LPexisting position · 161,700 shares now-664,299
New positions and exits
New (6)
Exited (4)
- Jane Street Group LLCwas $12m
- Squarepoint Ops LLCwas $2.1m
- Verition Fund Management LLCwas $784k
- Tudor Investment Corpwas $671k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2018 | 3 | $226m | n.a. | n.a. |
| Q3 2018 | 6 | $588m | n.a. | n.a. |
| Q4 2018 | 3 | $514m | n.a. | n.a. |
| Q1 2019 | 3 | $514m | n.a. | n.a. |
| Q2 2019 | 1 | $24m | n.a. | n.a. |
| Q4 2020 | 1 | $2k | n.a. | n.a. |
| Q1 2021 | 3 | $30m | n.a. | n.a. |
| Q2 2021 | 2 | $9.3m | n.a. | n.a. |
| Q3 2021 | 2 | $20m | n.a. | n.a. |
| Q4 2021 | 2 | $16m | n.a. | n.a. |
| Q1 2022 | 2 | $13m | n.a. | n.a. |
| Q2 2022 | 1 | $11m | n.a. | n.a. |
| Q3 2023 | 2 | $879k | n.a. | n.a. |
| Q4 2023 | 1 | $506k | 0 | 1 |
| Q1 2024 | 2 | $4.7m | 2 | 0 |
| Q2 2024 | 2 | $13m | 2 | 1 |
| Q3 2024 | 3 | $23m | 3 | 0 |
| Q4 2024 | 2 | $14m | 2 | 1 |
| Q1 2025 | 4 | $39m | 4 | 0 |
| Q2 2025 | 3 | $28m | 2 | 1 |
| Q3 2025 | 4 | $37m | 2 | 2 |
| Q4 2025 | 5 | $85m | 17 | 14 |
| Q1 2026 | 7 | $78m | 14 | 19 |
| Q2 2026 | 4 | $101m | 11 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AMRX and LLY →AMRX and JNJ →AMRX and VRTX →Choose a stock to compare with AMRX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AMRX, latest filings →Back to the 13F Explorer →